UA92169C2 - Fused heterocyclic compounds, process for the preparation thereof, pharmaceutical composition, crf receptor antagonist, tretment method and use of crf receptor antagonist - Google Patents
Fused heterocyclic compounds, process for the preparation thereof, pharmaceutical composition, crf receptor antagonist, tretment method and use of crf receptor antagonistInfo
- Publication number
- UA92169C2 UA92169C2 UAA200711851A UAA200711851A UA92169C2 UA 92169 C2 UA92169 C2 UA 92169C2 UA A200711851 A UAA200711851 A UA A200711851A UA A200711851 A UAA200711851 A UA A200711851A UA 92169 C2 UA92169 C2 UA 92169C2
- Authority
- UA
- Ukraine
- Prior art keywords
- optionally substituted
- receptor antagonist
- crf receptor
- preparation
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
There is provided a CRF receptor antagonist comprising a compound of the formula (I): wherein R1 is an optionally substituted hydrocarbyl, an optionally substituted C-linked heterocyclic group, an optionally substituted N-linked heteroaryl group, a cyano or an acyl; R2 is an optionally substituted cyclic hydrocarbyl or an optionally substituted heterocyclic group; X is oxygen, sulfur or -NR3-(wherein R3 is a hydrogen, an optionally substituted hydrocarbyl or an acyl); Y1, Y2 and Y3 are each an optionally substituted carbon or a nitrogen, provided that one or less of Y1, Y2 and Y3 is nitrogen; and Z is a bond, -CO-, oxygen, sulfur, -SO-, -SO-, -NR4-, -NR4-alk-, -CONR4- or -NR4CO- (wherein alk is an optionally substituted C3-4 alkylene and R4 is a hydrogen, an optionally substituted hydrocarbyl or an acyl); or a salt thereof or a prodrug thereof.(I)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67511305P | 2005-04-27 | 2005-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA92169C2 true UA92169C2 (en) | 2010-10-11 |
Family
ID=39334842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200711851A UA92169C2 (en) | 2005-04-27 | 2006-04-26 | Fused heterocyclic compounds, process for the preparation thereof, pharmaceutical composition, crf receptor antagonist, tretment method and use of crf receptor antagonist |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101166729B (en) |
| UA (1) | UA92169C2 (en) |
| ZA (1) | ZA200708844B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102153538B (en) * | 2010-02-11 | 2013-12-11 | 山东轩竹医药科技有限公司 | Benzocyclodirivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
| US6365589B1 (en) * | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
-
2006
- 2006-04-26 CN CN2006800147137A patent/CN101166729B/en not_active Expired - Fee Related
- 2006-04-26 UA UAA200711851A patent/UA92169C2/en unknown
-
2008
- 2008-04-26 ZA ZA200708844A patent/ZA200708844B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200708844B (en) | 2009-08-26 |
| CN101166729B (en) | 2011-08-31 |
| CN101166729A (en) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716639A (en) | Fused heterocyclic compounds | |
| NO20073729L (en) | Heterocyclic Compounds as CCR2B Antagonists | |
| TN2010000091A1 (en) | Substituted pyrazole derivative | |
| TW200611907A (en) | Fused heterocyclic compound | |
| MX2009010024A (en) | Novel adenine compound. | |
| WO2005044793A3 (en) | Nitrogen-containing fused heterocyclic compounds | |
| SI2091948T1 (en) | Novel inhibitors of glutaminyl cyclase | |
| MX344669B (en) | Novel anti-platelet agent. | |
| PE20130188A1 (en) | HETEROAROMATIC PYRROLIDINONES FUSED AS SYK INHIBITORS | |
| TW200510326A (en) | Heterocyclic compounds and thrombopoietin receptor activators | |
| PE20091842A1 (en) | PYRROLIDINONES AS GLUCOKINASE ACTIVATORS | |
| NO20073720L (en) | Heterocyclic substituted phenylmethanones as inhibitors of glycine transporters | |
| TW200738667A (en) | Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof | |
| MXPA03005822A (en) | Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them. | |
| NO20092689L (en) | Quinuclidinol derivatives as muscarinic receptor antagonists | |
| DE60235396D1 (en) | 3-AMIDO-1,2-BENZOXOXAZOLE DERIVATIVES, METHOD OF MANUFACTURE AND ITS USE | |
| NO20070173L (en) | New connections | |
| EA200800502A1 (en) | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUNDS, AND METHOD FOR THEIR PRODUCTION | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| MX2010008713A (en) | 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors. | |
| NO20064175L (en) | Heterocyclic compound | |
| GEP20084494B (en) | New heterocyclic carboxylic acid amide derivatives | |
| AU2003207432A1 (en) | Urea linker derivatives for use as ppar modulators | |
| FR2894578B1 (en) | HETEROCYCLIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE. | |
| NO20063111L (en) | Process for the preparation of thiazole pyrimidines |